Eosinophilic Gastritis Clinical Trial
Official title:
A Phase 3, Multicenter, Open-Label, Extension Study to Evaluate the Efficacy and Safety of AK002 in Patients That Were Previously Enrolled in AK002-016 or AK002-012 Studies and Have Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
This is a Phase 3, open-label, extension study to assess the long term efficacy and safety of lirentelimab given monthly.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03664960 -
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
|
Phase 2 | |
| Recruiting |
NCT05831176 -
A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT03678545 -
Dupilumab in Eosinophilic Gastritis
|
Phase 2 | |
| Completed |
NCT04322604 -
A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
|
Phase 3 | |
| Completed |
NCT03496571 -
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
|
Phase 2 | |
| Recruiting |
NCT02523118 -
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
|
||
| Recruiting |
NCT05229432 -
Study of Gastric Motility in Eosinophilic Gastritis
|
||
| Withdrawn |
NCT01779154 -
Eosinophilic Gastrointestinal Disorders Patient Registry
|
N/A | |
| Completed |
NCT05251909 -
Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)
|
Phase 3 | |
| Withdrawn |
NCT05152563 -
A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis
|
Phase 3 | |
| Completed |
NCT02897271 -
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
|